These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36335632)
1. Outcomes of catheter ablation for ventricular tachycardia in patients with sarcoidosis: Insights from the National Inpatient Sample database (2002-2018). Tan JL; Jin C; Lee JZ; Gaughan J; Iwai S; Russo AM J Cardiovasc Electrophysiol; 2022 Dec; 33(12):2585-2598. PubMed ID: 36335632 [TBL] [Abstract][Full Text] [Related]
2. Catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy: A propensity score-matched analysis of in-hospital outcomes in the United States. Briceño DF; Gupta T; Romero J; Kolte D; Khera S; Villablanca PA; Tran A; Mohanty S; Trivedi C; Mohanty P; Gianni C; Kim SG; Garcia M; Fonarow GC; Bhatt DL; Natale A; Di Biase L J Cardiovasc Electrophysiol; 2018 May; 29(5):771-779. PubMed ID: 29399923 [TBL] [Abstract][Full Text] [Related]
3. Long-Term Outcomes of Catheter Ablation of Ventricular Tachycardia in Patients With Cardiac Sarcoidosis. Muser D; Santangeli P; Pathak RK; Castro SA; Liang JJ; Magnani S; Hayashi T; Garcia FC; Hutchinson MD; Supple GE; Frankel DS; Riley MP; Lin D; Schaller RD; Desjardins B; Dixit S; Callans DJ; Zado ES; Marchlinski FE Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27516457 [TBL] [Abstract][Full Text] [Related]
4. Outcomes, Costs, and 30-Day Readmissions After Catheter Ablation of Myocardial Infarct-Associated Ventricular Tachycardia in the Real World: Nationwide Readmissions Database 2010 to 2015. Cheung JW; Yeo I; Ip JE; Thomas G; Liu CF; Markowitz SM; Lerman BB; Kim LK Circ Arrhythm Electrophysiol; 2018 Nov; 11(11):e006754. PubMed ID: 30376735 [TBL] [Abstract][Full Text] [Related]
6. Risk score model for predicting complications in patients undergoing ventricular tachycardia ablation: insights from the National Inpatient Sample database. Gunda S; Padala SK; Saini A; Kang L; Ellenbogen KA; Koneru JN Europace; 2019 Mar; 21(3):475-483. PubMed ID: 30304357 [TBL] [Abstract][Full Text] [Related]
7. Impact of the inflammation on the outcomes of catheter ablation of drug-refractory ventricular tachycardia in cardiac sarcoidosis. Kaur D; Roukoz H; Shah M; Yalagudri S; Pandurangi U; Chennapragada S; Narasimhan C J Cardiovasc Electrophysiol; 2020 Mar; 31(3):612-620. PubMed ID: 31916658 [TBL] [Abstract][Full Text] [Related]
8. Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation. Kumar S; Barbhaiya C; Nagashima K; Choi EK; Epstein LM; John RM; Maytin M; Albert CM; Miller AL; Koplan BA; Michaud GF; Tedrow UB; Stevenson WG Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):87-93. PubMed ID: 25527825 [TBL] [Abstract][Full Text] [Related]
9. Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis. Naruse Y; Sekiguchi Y; Nogami A; Okada H; Yamauchi Y; Machino T; Kuroki K; Ito Y; Yamasaki H; Igarashi M; Tada H; Nitta J; Xu D; Sato A; Aonuma K Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):407-13. PubMed ID: 24837644 [TBL] [Abstract][Full Text] [Related]
10. Outcome of cardiac sarcoidosis after radiofrequency ablation and placement of AICD- A propensity matched analysis. Bandyopadhyay D; Sahoo D; Zein J; Brunken RC; Tchou PJ; Culver DA Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jun; 32(1):70-9. PubMed ID: 26237358 [TBL] [Abstract][Full Text] [Related]
11. Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States. Palaniswamy C; Kolte D; Harikrishnan P; Khera S; Aronow WS; Mujib M; Mellana WM; Eugenio P; Lessner S; Ferrick A; Fonarow GC; Ahmed A; Cooper HA; Frishman WH; Panza JA; Iwai S Heart Rhythm; 2014 Nov; 11(11):2056-63. PubMed ID: 25016150 [TBL] [Abstract][Full Text] [Related]
12. Meta-Analysis of Catheter Ablation Outcomes in Patients With Cardiac Sarcoidosis Refractory Ventricular Tachycardia. Adhaduk M; Paudel B; Liu K; Ashwath M; Giudici M Am J Cardiol; 2022 Jul; 174():136-142. PubMed ID: 35504741 [TBL] [Abstract][Full Text] [Related]
13. Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review. Papageorgiou N; Providência R; Bronis K; Dechering DG; Srinivasan N; Eckardt L; Lambiase PD Europace; 2018 Apr; 20(4):682-691. PubMed ID: 28444174 [TBL] [Abstract][Full Text] [Related]
14. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Jefic D; Joel B; Good E; Morady F; Rosman H; Knight B; Bogun F Heart Rhythm; 2009 Feb; 6(2):189-95. PubMed ID: 19187909 [TBL] [Abstract][Full Text] [Related]
15. Clinical impact of mapping strategies for treatment of ventricular tachycardias in patients with structural heart disease. Makimoto H; Nakajima I; Miyamoto K; Yamada Y; Okamura H; Noda T; Aiba T; Kamakura S; Kusano K; Shimizu W; Satomi K Pacing Clin Electrophysiol; 2015 May; 38(5):630-40. PubMed ID: 25639823 [TBL] [Abstract][Full Text] [Related]
16. Safety and mid-term outcome of catheter ablation of ventricular tachycardia in octogenarians. Frontera A; Panniker S; Breitenstein A; Bruno VD; Connolly GM; Wilson D; Rio T; Dhinoja MB; Hussain W; Schilling RJ; Thomas G; Wong T; Hunter RJ; Sacher F; Jaïs P; Duncan E Europace; 2017 Aug; 19(8):1369-1377. PubMed ID: 27974359 [TBL] [Abstract][Full Text] [Related]